Jones Soda Co. (OTCMKTS:JSDA – Get Free Report) saw a significant increase in short interest during the month of May. As of May 15th, there was short interest totaling 22,958 shares, an increase of 132.8% from the April 30th total of 9,863 shares. Approximately 0.0% of the company’s shares are sold short. Based on an average daily trading volume, of 309,926 shares, the days-to-cover ratio is currently 0.1 days.
Jones Soda Stock Performance
Jones Soda stock traded down $0.00 during midday trading on Tuesday, hitting $0.28. 62,469 shares of the company’s stock were exchanged, compared to its average volume of 114,966. The firm has a 50-day moving average of $0.28 and a two-hundred day moving average of $0.27. Jones Soda has a 12 month low of $0.16 and a 12 month high of $0.40. The company has a market cap of $32.14 million, a PE ratio of -27.74 and a beta of 1.32.
Jones Soda (OTCMKTS:JSDA – Get Free Report) last issued its quarterly earnings data on Thursday, May 14th. The company reported $999.00 earnings per share for the quarter. The company had revenue of $12.43 million for the quarter. Jones Soda had a negative return on equity of 17.54% and a negative net margin of 2.42%.
About Jones Soda
Jones Soda Co is a Seattle-based beverage company known for its craft sodas featuring unconventional flavors and personalized label artwork. Founded in 1995, the company produces a variety of carbonated soft drinks, including its signature Tomato, Creamy Red & Black, and Blue Bubblegum flavors, alongside diet and zero-sugar alternatives. In addition to traditional soda offerings, Jones Soda has expanded its portfolio to include energy drinks, sparkling waters and limited-edition seasonal flavors that cater to niche consumer preferences.
Beyond its core product lineup, Jones Soda operates a direct-to-consumer ecommerce platform that allows customers to create custom photo labels for special occasions and corporate events.
Further Reading
- Five stocks we like better than Jones Soda
- Credo Technologies Paved a Path to a $300 Price Point
- Eli Lilly Wins Back CVS Health, Reverting Novo’s Advantage
- How the Latest Federal Contract Boosts D-Wave’s Prospects
- Alphabet’s $80 Billion Offering: Worrisome Dilution or AI Confidence?
Receive News & Ratings for Jones Soda Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jones Soda and related companies with MarketBeat.com's FREE daily email newsletter.
